Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Interparfums (IPAR) Other Accumulated Expenses (2017 - 2025)

Interparfums' Other Accumulated Expenses history spans 9 years, with the latest figure at $9.2 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 27.68% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $9.2 million, down 27.68%, while the annual FY2025 figure was $9.2 million, 27.68% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $9.2 million at Interparfums, down from $12.7 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $12.7 million in Q4 2024 and bottomed at $1.1 million in Q4 2022.
  • The 5-year median for Other Accumulated Expenses is $5.2 million (2021), against an average of $6.7 million.
  • The largest annual shift saw Other Accumulated Expenses crashed 78.1% in 2022 before it soared 355.35% in 2023.
  • A 5-year view of Other Accumulated Expenses shows it stood at $5.2 million in 2021, then plummeted by 78.1% to $1.1 million in 2022, then soared by 355.35% to $5.2 million in 2023, then skyrocketed by 142.66% to $12.7 million in 2024, then decreased by 27.68% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for IPAR's Other Accumulated Expenses are $9.2 million (Q4 2025), $12.7 million (Q4 2024), and $5.2 million (Q4 2023).